FCMI

Foresite Capital Management II Portfolio holdings

AUM $29.2M
1-Year Est. Return 44.84%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+44.84%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$201M
AUM Growth
-$87.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
21
New
Increased
Reduced
Closed

Top Buys

1
+$3.34M
2
+$2.56M
3
+$2.4M
4
RGLS
Regulus Therapeutics
RGLS
+$1.91M
5
XLRN
Acceleron Pharma
XLRN
+$1.07M

Top Sells

1
+$5.4M
2
+$3.08M
3
+$1.17M
4
BDSI
BioDelivery Sciences International, Inc.
BDSI
+$755K
5
LRMR icon
Larimar Therapeutics
LRMR
+$435K

Sector Composition

1 Healthcare 66.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$55.4M 27.52%
4,087,900
2
$20.1M 9.98%
2,814,883
3
$16.9M 8.42%
264,583
-66,816
4
$14.4M 7.17%
1,191,995
+32,200
5
$14.3M 7.11%
1,761,567
6
$14.1M 7.02%
16,991
+2,402
7
$13M 6.45%
530,416
+110,419
8
$11.5M 5.73%
949,372
+211,011
9
$10M 4.98%
659,486
+170,000
10
$9.5M 4.72%
118,523
-5,511
11
$4.59M 2.28%
174,089
+36,631
12
$3.64M 1.81%
468,297
-10,000
13
$3.64M 1.81%
646,208
+23,703
14
$2.93M 1.45%
887,801
+13,800
15
$2.4M 1.19%
743,395
-204,420
16
$1.69M 0.84%
156,741
17
$1.69M 0.84%
119,781
+64,002
18
$1.36M 0.67%
33,718
19
– –
0
20
– –
-8,125
21
– –
-4,804